表在性皮膚感染症に対するTMS-19-Q・GC錠の臨床的検討
書誌事項
- タイトル別名
-
- CLINICAL STUDIES ON TMS-19-Q·GC TABLET IN DERMATOLOGICAL SUPERFICIAL INFECTION
抄録
TMS-19-Q·GC tablet, a new developed macrolide antibiotic, was administered to 21 patients, 7 with folliculitis, 7 with furuncle, 3 with infectious atheroma and 4 with subcutaneous abscess at daily dose of 300mg or 400mg for 7-33 days.<BR>The results were summarized as follows: Cured in 15 cases, markedly improved in 3 cases, moderately improved in 3 cases.<BR>Effectiveness rate was 100% and neither side effect nor abnormal laboratory finding was observed in any case.
収録刊行物
-
- ＣＨＥＭＯＴＨＥＲＡＰＹ
-
ＣＨＥＭＯＴＨＥＲＡＰＹ 32 (Supplement6), 505-509, 1984
公益社団法人 日本化学療法学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282681258295168
-
- NII論文ID
- 130004194625
-
- ISSN
- 18845894
- 00093165
-
- データソース種別
-
- JaLC
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可